| RS1928574753 |
DCX
|
Health Risk |
Likely pathogenic |
Lissencephaly, Lissencephaly |
| RS1928578294 |
GLA
|
Health Risk |
Conflicting classifications of pathogenicity |
Fabry disease, Fabry disease |
| RS1928582757 |
GLA
|
Health Risk |
Pathogenic |
Fabry disease, Fabry disease |
| RS1928583820 |
GLA
|
Health Risk |
Pathogenic |
Fabry disease, Fabry disease |
| RS1928592578 |
GLA
|
Health Risk |
Conflicting classifications of pathogenicity |
Fabry disease, Fabry disease |
| RS1928595440 |
GLA
|
Health Risk |
Pathogenic |
Fabry disease, Fabry disease |
| RS192861143 |
DCAF17
|
Health Risk |
Conflicting classifications of pathogenicity |
Woodhouse-Sakati syndrome, Woodhouse-Sakati syndrome |
| RS192863214 |
ABCC8
|
Health Risk |
Pathogenic/Likely pathogenic |
Transitory neonatal diabetes mellitus, Maturity-onset diabetes of the young |
| RS192863498 |
ALMS1
|
Health Risk |
Conflicting classifications of pathogenicity |
Alstrom syndrome, Cardiovascular phenotype |
| RS192864327 |
DOCK8
|
Health Risk |
Conflicting classifications of pathogenicity |
Combined immunodeficiency due to DOCK8 deficiency, Intellectual disability |
| RS192869978 |
APOB
|
Health Risk |
Conflicting classifications of pathogenicity |
Cardiovascular phenotype, Hypercholesterolemia |
| RS192876326 |
SCARB2
|
Health Risk |
Conflicting classifications of pathogenicity |
Progressive myoclonic epilepsy, Action myoclonus-renal failure syndrome |
| RS192877602 |
GBE1
|
Health Risk |
Conflicting classifications of pathogenicity |
Glycogen storage disease, type IV |
| RS192879693 |
TET2
|
Health Risk |
Conflicting classifications of pathogenicity |
TET2-related disorder, TET2-related disorder |
| RS192880105 |
KIF1A
|
Health Risk |
Conflicting classifications of pathogenicity |
Neuropathy, hereditary sensory |
| RS192880210 |
DUOX2
|
Health Risk |
Conflicting classifications of pathogenicity |
Inborn genetic diseases, Inborn genetic diseases |
| RS1928842837 |
HNRNPH2
|
Health Risk |
Likely pathogenic |
Intellectual disability, X-linked |
| RS192889943 |
SPTA1
|
Health Risk |
Conflicting classifications of pathogenicity |
Pyropoikilocytosis, hereditary |
| RS192890834 |
RYR2
|
Health Risk |
Conflicting classifications of pathogenicity |
Cardiomyopathy, Catecholaminergic polymorphic ventricular tachycardia 1 |
| RS192892005 |
BRCA2
|
Health Risk |
Conflicting classifications of pathogenicity |
Hereditary breast ovarian cancer syndrome, Hereditary cancer-predisposing syndrome |
| RS192894455 |
DNAH5
|
Health Risk |
Pathogenic |
Primary ciliary dyskinesia, Primary ciliary dyskinesia |
| RS192896482 |
DNAI1
|
Health Risk |
Conflicting classifications of pathogenicity |
Primary ciliary dyskinesia, Primary ciliary dyskinesia |
| RS1928965653 |
CYBB
|
Health Risk |
Pathogenic |
Granulomatous disease, chronic |
| RS1928965951 |
CYBB
|
Health Risk |
Pathogenic |
Granulomatous disease, chronic |
| RS192897390 |
PSEN1
|
Health Risk |
Conflicting classifications of pathogenicity |
Alzheimer disease 3, Dilated cardiomyopathy 1U |
| RS1928998515 |
CYBB
|
Health Risk |
Conflicting classifications of pathogenicity |
Granulomatous disease, chronic |
| RS1929002470 |
ZC4H2
|
Health Risk |
Pathogenic |
Wieacker-Wolff syndrome, Wieacker-Wolff syndrome |
| RS1929006117 |
ZC4H2
|
Health Risk |
Pathogenic |
Wieacker-Wolff syndrome, Wieacker-Wolff syndrome |
| RS1929007323 |
ZC4H2
|
Health Risk |
Pathogenic |
Wieacker-Wolff syndrome, Wieacker-Wolff syndrome |
| RS192902098 |
PDX1
|
Health Risk |
Conflicting classifications of pathogenicity |
Maturity-onset diabetes of the young type 4, Type 2 diabetes mellitus |
| RS1929024034 |
KLHL15
|
Health Risk |
Pathogenic |
Intellectual disability, X-linked 103 |
| RS1929057155 |
ZC4H2
|
Health Risk |
Likely pathogenic |
— |
| RS1929057804 |
ZC4H2
|
Health Risk |
Likely pathogenic |
Wieacker-Wolff syndrome, Wieacker-Wolff syndrome |
| RS1929070198 |
ZC4H2
|
Health Risk |
Pathogenic |
Wieacker-Wolff syndrome, female-restricted |
| RS192907397 |
RPE65
|
Health Risk |
Likely pathogenic |
Leber congenital amaurosis, Retinitis pigmentosa 20 |
| RS192909520 |
NRXN1
|
Health Risk |
Conflicting classifications of pathogenicity |
Pitt-Hopkins-like syndrome 2, Inborn genetic diseases |
| RS192910004 |
FAT1
|
Health Risk |
Conflicting classifications of pathogenicity |
FAT1-related disorder, FAT1-related disorder |
| RS1929106223 |
SMARCB1
|
Health Risk |
Pathogenic |
Schwannomatosis, Schwannomatosis |
| RS1929117983 |
SMARCB1
|
Health Risk |
Pathogenic |
— |
| RS192912251 |
MBTPS1
|
Health Risk |
Conflicting classifications of pathogenicity |
Inborn genetic diseases, Inborn genetic diseases |
| RS192912733 |
CNGA1
|
Health Risk |
Conflicting classifications of pathogenicity |
Retinitis pigmentosa 49, Retinitis pigmentosa |
| RS1929135614 |
ZC4H2
|
Health Risk |
Pathogenic |
Wieacker-Wolff syndrome, female-restricted |
| RS1929136990 |
ZC4H2
|
Health Risk |
Pathogenic |
Wieacker-Wolff syndrome, Inborn genetic diseases |
| RS1929150904 |
PHEX
|
Health Risk |
Pathogenic |
— |
| RS1929155885 |
PHEX
|
Health Risk |
Pathogenic |
— |
| RS1929158021 |
PHEX
|
Health Risk |
Pathogenic |
Familial X-linked hypophosphatemic vitamin D refractory rickets, Familial X-linked hypophosphatemic vitamin D refractory rickets |
| RS1929191668 |
FRMD7
|
Health Risk |
Pathogenic |
Nystagmus 1, congenital |
| RS192919234 |
TUBGCP6
|
Health Risk |
Pathogenic |
Microcephaly and chorioretinopathy with or without intellectual disability, Microcephaly and chorioretinopathy 1 |
| RS1929193313 |
FRMD7
|
Health Risk |
Pathogenic |
Inborn genetic diseases, Inborn genetic diseases |
| RS1929200391 |
PHEX
|
Health Risk |
Pathogenic |
— |
| RS1929202609 |
PHEX
|
Health Risk |
Pathogenic |
— |
| RS1929202828 |
PHEX
|
Health Risk |
Pathogenic |
Familial X-linked hypophosphatemic vitamin D refractory rickets, Familial X-linked hypophosphatemic vitamin D refractory rickets |
| RS1929207873 |
ZC4H2
|
Health Risk |
Pathogenic |
Wieacker-Wolff syndrome, female-restricted |
| RS1929210900 |
PHEX
|
Health Risk |
Pathogenic |
— |
| RS1929214770 |
PHEX
|
Health Risk |
Pathogenic |
Familial X-linked hypophosphatemic vitamin D refractory rickets, Familial X-linked hypophosphatemic vitamin D refractory rickets |
| RS1929215753 |
PHEX
|
Health Risk |
Pathogenic |
— |
| RS1929216641 |
ZC4H2
|
Health Risk |
Pathogenic |
Wieacker-Wolff syndrome, female-restricted |
| RS1929218157 |
PHEX
|
Health Risk |
Likely pathogenic |
Familial X-linked hypophosphatemic vitamin D refractory rickets, Familial X-linked hypophosphatemic vitamin D refractory rickets |
| RS1929219058 |
PHEX
|
Health Risk |
Pathogenic |
Familial X-linked hypophosphatemic vitamin D refractory rickets, Familial X-linked hypophosphatemic vitamin D refractory rickets |
| RS1929220357 |
PHEX
|
Health Risk |
Pathogenic/Likely pathogenic |
Familial X-linked hypophosphatemic vitamin D refractory rickets, Familial X-linked hypophosphatemic vitamin D refractory rickets |
| RS192923161 |
HARS1
|
Health Risk |
Conflicting classifications of pathogenicity |
Usher syndrome type 3B, Usher syndrome type 3B |
| RS192923495 |
DHODH
|
Health Risk |
Conflicting classifications of pathogenicity |
Miller syndrome, Miller syndrome |
| RS192924272 |
MMACHC
|
Health Risk |
Conflicting classifications of pathogenicity |
Cobalamin C disease, Cobalamin C disease |
| RS1929244686 |
CYBB
|
Health Risk |
Pathogenic |
Granulomatous disease, chronic |
| RS1929245964 |
CYBB
|
Health Risk |
Likely pathogenic |
Granulomatous disease, chronic |
| RS192928196 |
SETX
|
Health Risk |
Conflicting classifications of pathogenicity |
Inborn genetic diseases, Amyotrophic lateral sclerosis type 4 |
| RS192930227 |
COL6A3
|
Health Risk |
Conflicting classifications of pathogenicity |
Bethlem myopathy 1A, Dystonia 27 |
| RS1929302971 |
CYBB
|
Health Risk |
Pathogenic |
Granulomatous disease, chronic |
| RS1929304640 |
CYBB
|
Health Risk |
Pathogenic |
Granulomatous disease, chronic |
| RS192935024 |
ABCA1
|
Health Risk |
Conflicting classifications of pathogenicity |
Tangier disease, Hypoalphalipoproteinemia |
| RS1929354169 |
CRYBB1
|
Health Risk |
Likely pathogenic |
Cataract 17 multiple types, Cataract 17 multiple types |
| RS1929376118 |
CYBB
|
Health Risk |
Pathogenic |
Granulomatous disease, chronic |
| RS192942248 |
VPS13A
|
Health Risk |
Conflicting classifications of pathogenicity |
Chorea-acanthocytosis, Chorea-acanthocytosis |
| RS1929431693 |
CYBB
|
Health Risk |
Pathogenic |
— |
| RS1929432929 |
CYBB
|
Health Risk |
Pathogenic |
Granulomatous disease, chronic |
| RS192944055 |
OTOGL
|
Health Risk |
Conflicting classifications of pathogenicity |
OTOGL-related disorder, OTOGL-related disorder |
| RS1929471370 |
LARGE1
|
Health Risk |
Pathogenic |
Muscular dystrophy-dystroglycanopathy type B6, Muscular dystrophy-dystroglycanopathy type B6 |
| RS192949406 |
NDUFS1
|
Health Risk |
Conflicting classifications of pathogenicity |
Leigh syndrome, Mitochondrial complex I deficiency |
| RS1929497736 |
CYBB
|
Health Risk |
Pathogenic |
Granulomatous disease, chronic |
| RS1929499524 |
CYBB
|
Health Risk |
Pathogenic |
Granulomatous disease, chronic |
| RS1929500338 |
CYBB
|
Health Risk |
Pathogenic |
Granulomatous disease, chronic |
| RS1929527785 |
CYBB
|
Health Risk |
Likely pathogenic |
Granulomatous disease, chronic |
| RS192952800 |
DNMT1
|
Health Risk |
Conflicting classifications of pathogenicity |
Hereditary sensory neuropathy-deafness-dementia syndrome, Hereditary sensory neuropathy-deafness-dementia syndrome |
| RS1929531349 |
CYBB
|
Health Risk |
Pathogenic |
Granulomatous disease, chronic |
| RS192954755 |
ENTPD1
|
Health Risk |
Conflicting classifications of pathogenicity |
Hereditary spastic paraplegia 64, Clear cell carcinoma of kidney |
| RS1929563459 |
CYBB
|
Health Risk |
Pathogenic |
Granulomatous disease, chronic |
| RS1929577517 |
ANOS1
|
Health Risk |
Likely pathogenic |
See cases, See cases |
| RS1929590555 |
MID1
|
Health Risk |
Pathogenic |
— |
| RS1929600096 |
MID1
|
Health Risk |
Likely pathogenic |
X-linked Opitz G/BBB syndrome, X-linked Opitz G/BBB syndrome |
| RS1929601378 |
PI4KA
|
Health Risk |
Pathogenic |
Polymicrogyria, perisylvian |
| RS1929603954 |
ANOS1
|
Health Risk |
Pathogenic |
Hypogonadotropic hypogonadism 1 with or without anosmia, Hypogonadotropic hypogonadism 1 with or without anosmia |
| RS192962624 |
TTN
|
Health Risk |
Conflicting classifications of pathogenicity |
Dilated cardiomyopathy 1G, Autosomal recessive limb-girdle muscular dystrophy type 2J |
| RS192964209 |
NDUFA10
|
Health Risk |
Conflicting classifications of pathogenicity |
Mitochondrial complex I deficiency, nuclear type 1 |
| RS1929657778 |
AR
|
Health Risk |
Pathogenic |
Androgen resistance syndrome, Androgen resistance syndrome |
| RS1929658430 |
CYBB
|
Health Risk |
Pathogenic |
Granulomatous disease, chronic |
| RS1929660142 |
AR
|
Health Risk |
Pathogenic |
Kennedy disease, Androgen resistance syndrome |
| RS1929664860 |
AR
|
Health Risk |
Pathogenic |
— |
| RS1929675709 |
CRYBA4
|
Health Risk |
Likely pathogenic |
Cataract 23, Cataract 23 |
| RS1929683441 |
AR
|
Health Risk |
Pathogenic |
Androgen resistance syndrome, Kennedy disease |
| RS192968747 |
MKKS
|
Health Risk |
Conflicting classifications of pathogenicity |
McKusick-Kaufman syndrome, Bardet-Biedl syndrome |